Themis Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

THEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.5%1-day move

₹71.49

prior close

₹72.90

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.6+0.3+0.5+0.7-1.5-6.3+2.8+11.0+13.3+13.5+29.4+36.0+41.1+59.5

Up moveDown movePending

AI summary

Gujarat Themis Biosyn Limited has informed the stock exchanges that the trading window for dealing in its shares will be closed from Wednesday, 1st April 2026. The window will reopen 48 hours after the Board declares the audited financial results for the quarter and year ending 31st March 2026. The Board meeting date to approve these results will be communicated separately. This is a routine compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015, aimed at preventing insiders from trading while in possession of unpublished price-sensitive information.

Likely market impact

This is a standard regulatory filing with no material impact on shareholders or the stock price. Insiders, including directors and designated employees, cannot trade in the company's shares during the closed window. Retail investors are not restricted but should note that upcoming Q4 results could influence the stock once the window reopens.